Investing Center Preview – Manage your investments and watch your net worth grow.
DGX:NYSE – Large Cap Stock (Diagnostics & Research)
Quest Diagnostics Inc – DGX Stock Overview
Last Price | Today's Change | 52-Week Range | Trading Volume |
---|---|---|---|
163.99 | 0.14 (+0.09%) | 125.42 - 178.87 | 2.2 million (Above Avg) |
Market data as of 4:00PM 04/11/25. Quotes are delayed by at least 15 min.
Overview - DGX
Open | 163.85 |
---|---|
Previous Close | 163.85 |
Day's Range | 161.60 - 165.06 |
Market Cap | 18.2B |
Avg Volume (10 Day) | 1.9M |
Price/Earnings (Trailing 12 Mo.) | 21.3x |
Earnings Per Share (Trailing 12 Mo.) | 3.87 |
Dividend Yield | 0.80 (1.95%) |
One-Click Scorecard - DGX


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Performed well consistently? | Fail |
---|---|
Avoids excess debt? | Pass |
Converting sales to profits? | Pass |
Shareholder's money handled rationally? | Pass |
Increased shareholder value? | Fail |
Consistently increased owner earnings? | Pass |
Sells at 25% discount to intrinsic value? | Neutral |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Pays a cash dividend? | Pass |
---|---|
Room to increase dividends? | Pass |
Increased earnings over time? | Pass |
Borrows within reasonable limits? | Fail |
Stock is undervalued? | Pass |
Have investors caught on? | Fail |
Has support of institutional investors? | Pass |
Has sufficient liquidity? | Pass |
Latest Headlines - DGX
Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease
PR Newswire - Wednesday 04/09/2025 7:53 AM ET
Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening
PR Newswire - Wednesday 04/02/2025 7:06 AM ET
Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025
PR Newswire - Tuesday 04/01/2025 4:23 PM ET
Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day
PR Newswire - Wednesday 03/19/2025 7:52 AM ET
Quest Diagnostics to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI
PR Newswire - Tuesday 03/18/2025 9:00 AM ET
Industry Position - DGX
DGX | Industry Range | |
---|---|---|
Revenue Growth (1yr) | 6.70% | |
Net Income Growth (1yr) | 1.99% | |
Total Debt/Equity | 1.05 | |
LT Debt/Equity | 0.91 | |
Earnings Yield | 4.69% | |
Price/Sales | 1.88 |
Competitors - DGX
Company | Last | Change |
---|---|---|
Labcorp Holdings Inc | 221.46 | +1.30% |
Waters Corp | 325.22 | +3.36% |
1138.00 | +2.89% | |
Natera Inc | 148.04 | +3.32% |
49.21 | +1.46% |
Data is delayed by at least 15 min.